Sofosbuvir Plus Daclatasvir Without Ribavirin for the Treatment of Chronic Hepatitis C in Patients With Decompensated Liver Disease: Response of Sofosbuvir Plus Daclatasvir in Decompensated Cirrhosis. J Fatima Jinnah Med Univ 2020, 14 (1), 41-44. https://doi.org/10.37018/WOXS1774.